Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Fertility preservation in young patients before allogeneic haematopoietic SCT.

Bastings L, Westphal JR, Beerendonk CC, Braat DD, Peek R.

Bone Marrow Transplant. 2012 Feb;47(2):313-4. doi: 10.1038/bmt.2011.235. Epub 2011 Nov 28. No abstract available.

PMID:
22120985
[PubMed - indexed for MEDLINE]
2.

Fertility considerations in young women with hematological malignancies.

Jadoul P, Kim SS; ISFP Practice Committee.

J Assist Reprod Genet. 2012 Jun;29(6):479-87. doi: 10.1007/s10815-012-9792-0. Epub 2012 May 22. Review.

PMID:
22614159
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer.

ISFP Practice Committee, Kim SS, Donnez J, Barri P, Pellicer A, Patrizio P, Rosenwaks Z, Nagy P, Falcone T, Andersen C, Hovatta O, Wallace H, Meirow D, Gook D, Kim SH, Tzeng CR, Suzuki S, Ishizuka B, Dolmans MM.

J Assist Reprod Genet. 2012 Jun;29(6):465-8. doi: 10.1007/s10815-012-9786-y. Epub 2012 May 31. Erratum in: J Assist Reprod Genet. 2012 Oct;29(10):1155.

PMID:
22648282
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies.

Chatterjee R, Kottaridis PD.

Bone Marrow Transplant. 2002 Nov;30(10):629-35. Review.

PMID:
12420200
[PubMed - indexed for MEDLINE]
Free Article
5.

[Semen cryopreservation in adolescent with cancer: at which age can it be proposed?].

Laverdure N, d'Estaing SG, Marec-Berard P.

Bull Cancer. 2012 Oct;99(10):935-41. French.

PMID:
23289135
[PubMed - indexed for MEDLINE]
6.

Fertility issues following hematopoietic stem cell transplantation.

Tichelli A, Rovó A.

Expert Rev Hematol. 2013 Aug;6(4):375-88. doi: 10.1586/17474086.2013.816507. Review.

PMID:
23991924
[PubMed - indexed for MEDLINE]
7.

Occult autologous haematopoietic regeneration without disease relapse following myeloablative allogeneic haematopoietic SCT for lymphomas.

Au WY, Lam KK, Leung AY, Liang RH, Lie AK, Kwong YL.

Bone Marrow Transplant. 2010 Aug;45(8):1377-8. doi: 10.1038/bmt.2009.356. Epub 2009 Dec 21. No abstract available.

PMID:
20023709
[PubMed - indexed for MEDLINE]
8.

Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence.

Borgmann-Staudt A, Rendtorff R, Reinmuth S, Hohmann C, Keil T, Schuster FR, Holter W, Ehlert K, Keslova P, Lawitschka A, Jarisch A, Strauss G.

Bone Marrow Transplant. 2012 Feb;47(2):271-6. doi: 10.1038/bmt.2011.78. Epub 2011 Apr 11.

PMID:
21478918
[PubMed - indexed for MEDLINE]
9.

Fertility preservation for cancer patients. Current options.

Shalom-Paz E, Holzer HE.

Minerva Ginecol. 2011 Dec;63(6):517-30. Review.

PMID:
22036756
[PubMed - indexed for MEDLINE]
10.

Medical, ethical, and legal considerations in fertility preservation.

Shah DK, Goldman E, Fisseha S.

Int J Gynaecol Obstet. 2011 Oct;115(1):11-5. doi: 10.1016/j.ijgo.2011.05.011. Epub 2011 Jul 20. Review.

PMID:
21767834
[PubMed - indexed for MEDLINE]
11.

Timing of fertility preservation procedures in a cohort of female patients with cancer.

Jenninga E, Louwe LA, Peters AA, Nortier JW, Hilders CG.

Eur J Obstet Gynecol Reprod Biol. 2012 Feb;160(2):170-3. doi: 10.1016/j.ejogrb.2011.11.011. Epub 2011 Dec 3.

PMID:
22137982
[PubMed - indexed for MEDLINE]
12.

Combination of fertility preservation strategies in young women with recently diagnosed cancer.

Huser M, Zakova J, Smardova L, Crha I, Janku P, Hudecek R, Ventruba P.

Eur J Gynaecol Oncol. 2012;33(1):42-50.

PMID:
22439404
[PubMed - indexed for MEDLINE]
13.

Integration and safety of fertility preservation in a breast cancer program.

Westphal LM, Wapnir IL.

Gynecol Oncol. 2012 Mar;124(3):474-6. doi: 10.1016/j.ygyno.2011.11.028. Epub 2011 Nov 22.

PMID:
22173210
[PubMed - indexed for MEDLINE]
14.

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.

Talmadge JE.

Int Immunopharmacol. 2003 Aug;3(8):1121-43. Review.

PMID:
12860168
[PubMed - indexed for MEDLINE]
15.

Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies.

Branson K, Chopra R, Kottaridis PD, McQuaker G, Parker A, Schey S, Chakraverty RK, Craddock C, Milligan DW, Pettengell R, Marsh JC, Linch DC, Goldstone AH, Williams CD, Mackinnon S.

J Clin Oncol. 2002 Oct 1;20(19):4022-31.

PMID:
12351600
[PubMed - indexed for MEDLINE]
16.

Non-endocrine late complications in children after allogeneic haematopoietic SCT.

Faraci M, Békássy AN, De Fazio V, Tichelli A, Dini G; EBMT Paediatric and Late Effects Working Parties.

Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S49-57. doi: 10.1038/bmt.2008.55. Review.

PMID:
18545245
[PubMed - indexed for MEDLINE]
17.

Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.

Porter DL, Luger SM, Duffy KM, Stadtmauer EA, Laport G, Schuster SJ, Orloff G, Tsai D, McDaid K, Kathakali A, Leonard DG, Antin JH.

Biol Blood Marrow Transplant. 2001;7(4):230-8.

PMID:
11349810
[PubMed - indexed for MEDLINE]
18.

Long-term oral complications of allogeneic haematopoietic SCT.

Hull KM, Kerridge I, Schifter M.

Bone Marrow Transplant. 2012 Feb;47(2):265-70. doi: 10.1038/bmt.2011.63. Epub 2011 Mar 28.

PMID:
21441960
[PubMed - indexed for MEDLINE]
19.

[Non-myeloablative allogeneic stem cell transplantation].

Dalgaard J, Fløisand Y, Stenersen M, Egeland T, Brinch L.

Tidsskr Nor Laegeforen. 2007 Mar 15;127(6):721-4. Norwegian.

PMID:
17363982
[PubMed - indexed for MEDLINE]
Free Article
20.

[Allogeneic hematopoietic stem cell transplantations].

Michallet M.

Transfus Clin Biol. 2011 Apr;18(2):235-45. doi: 10.1016/j.tracli.2011.02.021. Epub 2011 Apr 3. Review. French.

PMID:
21466967
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk